Arvind Remedies has signed Memorandum of Understanding (MoU) with SRM University, Chennai, to transfer the patent right to undertake exclusive manufacturing and marketing of drugs for Type II Diabetes and Coronary heart disease.
These drugs will be manufactured in the form of tablets and will be launched in the domestic market by 2015 followed by the global market. The Diabetes drug is from the botanical source to ensure zero side effects on the health of patients.
Arvind Remedies is engaged in the manufacturing of pharmaceutical formulations such as tablets, capsules (including soft gels), ointments and liquids. ARL markets its products in the institutional (primarily government organizations) and ethical segments, with institutional segment contributing to 70% of the total revenues.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.90 |
| Dr. Reddys Lab | 1233.00 |
| Cipla | 1230.95 |
| Zydus Lifesciences | 937.65 |
| Lupin | 2326.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: